Eradication of tetanus

British Medical Bulletin

Volumn 116, Issue 1, 2015, Pages 69-77

  Thwaites, C L ^a,b   Loan, H T ^c  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

elimination; maternal; neonatal tetanus; tetanus

Indexed keywords

ANTIBODY; TETANUS TOXOID;

EMERGENCY CARE; HEALTH CARE ACCESS; HOSPITAL HYGIENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALARIA; MATERNAL MORTALITY; NEWBORN CARE; NEWBORN MORTALITY; NEWBORN TETANUS; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; POST EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VACCINATION; WOUND CARE; FEMALE; IMMUNOLOGY; MIXED INFECTION; PRENATAL EXPOSURE; PROCEDURES; TETANUS; TRANSMISSION;

COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALARIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TETANUS; TETANUS TOXOID; VACCINATION;

EID: 84950297547     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldv044     Document Type: Review

References (50)

1. Thwaites CL, Yen LM, Nga NT, et al. Impact of improved vaccination programme and intensive care facilities on incidence and outcome of tetanus in southern Vietnam, 1993-2002. Trans R Soc Trop Med Hyg 2004;98:671-7.
2. Mull DS, Anderson JW, Mull JD. Cow dung, rock salt, and medical innovation in the Hindu Kush of Pakistan: the cultural transformation of neonatal tetanus and iodine deficiency. Soc Sci Med 1990;30:675-91.
3. Salinas S, Schiavo G, Kremer EJ. A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol 2010;8:645-55.
4. Deinhardt K, Salinas S, Verastegui C, et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 2006;52:293-305.
5. Fishman PS, Carrigan DR. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin. Arch Neurol 1988;45:558-61.
6. Schiavo G, Benfanati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359: 832-5.
7. Udwadia FE. Tetanus. Oxford University Press, 1994.
8. Verde F, Riboldi G, Zappa C, et al. An old woman with pressure ulcer, rigidity, and opisthotonus: never forget tetanus! Lancet 2014;384:2266.
9. Alves M, Canoui L, Deforges L, et al. An unexpected trismus. Lancet 2012;380:536.
10. Public Health England. Tetanus in England and Wales: 2013. https://www.gov.uk/government/publications/tetanusin-england-and-wales-2013/tetanus-in-england-and-wales- 2013 (October 2015, date last accessed).
11. Sutter RW, Cochi S, Brink E, et al. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, united states, 1979-1984. Am J Epidemiol 1990;131:132-42.
12. World Health Organization. Tetanus-2005 Global Figures, Geneva. http://www.who.int/immunization-monitoring/diseases/tetanus/en/index.html (October 2015, date last accessed).
13. Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet 2015;385:362-70.
14. World Health Assembly Expanded Program on Immunization. Resolution WHA 42.32; 1989.
15. Department of Health Immunisation against infectious disease. Chapter 30. Tetanus. https://www.gov.uk/government/publications/tetanus-the-green-book-chapter-30 (October 2015, date last accessed).
16. Borrow R, Balmer P, Roper M. The immunological basis for immunization series. Module 3: Tetanus update 2006. World Health Organisation 2006.
17. Beeching NJ, Crowcroft N. Tetanus in injecting drug users. BMJ 2005;330:208-9.
18. Hope VD, Palmateer N, Wiessing L, et al. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. Am J Public Health 2012;102:122-5.
19. Department of Violence and Injury Prevention and Disability & Organization, W. H. Prevention and management of wound infection guidance from WHO's department of violence and injury prevention and disability and the department of essential health technologies. 1-3. www.who.int/hac/techguidance/tools/guidelines-prevention-and-management-wound-infection.pdf (October 2015, date last accessed).
20. Perey F. Progress in tetanus prophylaxis: the advent of human antitoxin. Canadian Med Ass J 1966;94:437-41.
21. Health Protection Agency. HPA expert working group interim guidance on the use of tetanus immunoglobulin for the treatment of Tetanus. 1-2 (2013). https://www.gov. uk/government/uploads/system/uploads/attachment-data/file/400084/expert-working-group-interim-guidance-on-the-use-of-tetanus-immunoglobulin-for-the-treatment-of-Tetanus.pdf (October 2015, date last accessed).
22. Lam PK, Trieu HT, Lubis IN, et al. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants. Int J Infect Dis 2014; 33C:7-11.
23. WHO Maternal and Neonatal Tetanus (MNT) elimination. http://www.who.int/immunization-monitoring/diseases/MNTE-initiative/en/index.html (October 2015, date last accessed).
24. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375:1969-87.
25. Fauveau V, Mamdani M, Steinglass R, et al. Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obstet 1993;40:3-12.
26. Khan AA, Zahidie A, Rabbani F. Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries-a systematic review. BMC Public Health 2013;13:322.
27. Blencowe H, Lawn J, Vandelaer J, et al. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol 2010;39:i102-9.
28. Singh A, Pallikadavath S, Ogollah R, et al. Maternal tetanus toxoid vaccination and neonatal mortality in rural north India. PloS One 2012;7:e48891.
29. Vandelaer J, Partridge J, Suvedi BK. Process of neonatal tetanus elimination in Nepal. J Public Health 2009;31: 561-5.
30. Stanfield J, Galazka A. Neonatal tetanus in the world today. Bull WHO1984;62:647-69.
31. Datta SS, Barnabas R, Sitther A, et al. Three cases of neonatal tetanus in Papua New Guinea lead to the development of national action plan for maternal and neonatal tetanus elimination. WPSAR 2013;4:8-11.
32. WHO Making pregnancy safer: the critical role of the skilled attendant. A joint statement by WHO, ICM and FIGO, 2004. http://whqlibdoc.who.int/publications/2004/9241591692.pdf (October 2015, date last accessed).
33. Blencowe H, Cousens S, Mullany L, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11 Suppl 3:S11.
34. Raza S, Avan BI. Disposable clean delivery kits and prevention of neonatal tetanus in the presence of skilled birth attendants. Int J Gynaecol Obstet 2013;120:148-51.
35. WHO Progress towards global MNT elimination. http://www.who.int/immunization-monitoring/diseases/MNTE-initiative/en/index4.html (October 2015, date last accessed).
36. Cutts FT, Izurieta HS, Rhoda D. Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys. PLoSMed 2013;10:e1001404.
37. WHO World Health Statistics 2014, 2013. http://apps. who.int/iris/bitstream/10665/81965/1/9789241564588-eng.pdf (October 2015, date last accessed).
38. Health Protection Agency. Tetanus: information for health professionals. 1-9 (2013). https://www.gov.uk/government/publications/tetanus-advice-for-health-professionals (October 2015, date last accessed).
39. Aboud S, Matre R, Lyamuya EF, et al. Levels and avidity of antibodies to tetanus toxoid in children aged 1-15 years in Dar es Salaam and Bagamoyo, Tanzania. Ann Trop Paediatr 2000;20:313-22.
40. Mvundura M, Kien VD, Nga NT, et al. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization. Vaccine 2014; 32:834-8.
41. Kroon F, Van Dissel J, Labadie J, et al. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 1995;21:1197-203.
42. Bonetti T, Succi R, Weckx L, et al. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 2004;22:3707-12.
43. Brabin BJ, Nagel J, Hagenaars AM, et al. The influence of malaria and gestation on the immune response to one and two doses of adsorbed tetanus toxoid in pregnancy. Bull WHO1984;62:919-30.
44. Cumberland P, Shulman CE, Maple PA, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007;196:550-7.
45. Brair ME, Brabin BJ, Milligan P, et al. Reduced transfer of tetanus antibodies with placental malaria. Lancet 1994;343:208-9.
46. Liu X, Yan H, Wang D. The evaluation of 'Safe Motherhood' program on maternal care utilization in rural western China: a difference in difference approach. BMC Public Health 2010;10:566.
47. Afshar M, Raju M, Ansell D, et al. Annals of internal medicine review narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Int Med 2011;154:329-36.
48. Jeremijenko A, McLaws M, Kosasih H. A tsunami related tetanus epidemic in Aceh, Indonesia. Asia Pac J Public Health 2007;19:40-4.
49. Huang SW, Chan JP, Shia WY, et al. The utilization of a commercial soil nucleic acid extraction kit and PCR for the detection of clostridium tetanus and clostridium chauvoei on farms after flooding in Taiwan. J Vet Med Sci 2013;75:489-95.
50. World Health Organization. WHO current recommendations for treatment of tetanus during humanitarian emergencies, 2010. http://whqlibdoc.who.int/hq/2010/WHO-HSE-GAR-DCE-2010.2-eng.pdf (October 2015, date last accessed).